Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
Total published articles |
123 | 107 | 59 | 61 | 45 | 23 |
Research, Review articles and Editorials |
44 | 54 | 37 | 40 | 21 | 22 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
5 | 1 | 2 | 5 | 3 | 0 |
Conference proceedings |
6 | 16 | 5 | 7 | 0 | 45 |
Citations received as per Google Scholar, other indexing platforms and portals |
632 | 946 | 1156 | 1199 | 1039 | 1106 |
| Journal total citations count | 10648 |
| Journal impact factor | 12.50 |
| Journal 5 years impact factor | 18.23 |
| Journal cite score | 23.62 |
| Journal h-index | 43 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
HimaBindu A, Soumya D. Incidence of Diabetes and its Control Measures in AIDS Patients. J Diabetes Metab. 2011;2(169):2. |
|
Arun Kumar R, Sathish Kumar D, Nishanth T. A review on stem cell research & their role in various diseases. J Stem Cell Res Ther. 2011;1(112):2. |
|
Elekofehinti OO, Ejelonu OC, Kamdem JP, Akinlosotu OB, Adanlawo IG. Saponins as adipokines modulator: A possible therapeutic intervention for type 2 diabetes. World journal of diabetes. 2017 Jul 15;8(7):337. |
|
Vanita P, Jhansi K. Metabolic syndrome in endocrine system. J diabetes Metab. 2011;2(163):2. |
|
Sai YR, Dattatreya A, Anand SY, Suresh Babu D, Sandeep Heni RS. Biomarkers of internal origin and their significance in diabetes and diabetic complications. J Diabetes Metab. 2011;2. |
|
Mazibuko SE. In vitro and in vivo effect of Aspalathus linearis and its major polyphenols on carbohydrate and lipid metabolism in insulin resistant models (Doctoral dissertation, University of Zululand). |
|
Miao X, Wang Y, Wang W, Lv X, Wang M, Yin H. The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway. Molecular and cellular endocrinology. 2015 Mar 5;403:1-9. |
|
Mazibuko SE, Joubert E, Johnson R, Louw J, Opoku AR, Muller CJ. Aspalathin improves glucose and lipid metabolism in 3T3â€L1 adipocytes exposed to palmitate. Molecular nutrition & food research. 2015 Nov;59(11):2199-208. |
|
Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011 Dec 25;2(9):1000167. |
|
Mazibuko SE, Muller CJ, Joubert E, De Beer D, Johnson R, Opoku AR, Louw J. Amelioration of palmitate-induced insulin resistance in C2C12 muscle cells by rooibos (Aspalathus linearis). Phytomedicine. 2013 Jul 15;20(10):813-9. |
|
Cheptea E, Gonciar V. Unele efecte ale interacţiunii asocierii izoturon-propranolol cu oxigenul hiperbaric la nivelul metabolismului lipidic. |
|
Bacinschi N, Ghicavîi V, Baltag N, Bacinschi A, Morneală E. Realizări ÅŸi perspective în tratamentul diabetului zanarat tip 2. |
|
Bacinschi N, Ghicavîi V, Baltag N, Bacinschi A, Morneală E. FARMACOLOGIE ÅžI FARMACOLOGIE CLINICÄ‚. |
|
Fouqueray P, Hallakou-Bozec S, Bolze S, Lebovitz HE. Imeglimin Improves Vascular Dysfunction in Type 2 Diabetes Animal Models. InDIABETOLOGIA 2016 Aug 1 (Vol. 59, pp. S341-S341). 233 SPRING ST, NEW YORK, NY 10013 USA: SPRINGER. |
|
Konstantinos P. FACULTY OF HEALTH SCIENCES SCHOOL OF MEDICINE (Doctoral dissertation, ARISTOTLE UNIVERSITY OF THESSALONIKI). |
|
Glandt M, Bloomgarden Z. The Future of Diabetes 52. Principles of Diabetes Mellitus. 2017:999. |
|
RaczynÌska ED, Gal JF, Maria PC, Fontaine-Vive F. Biguanide Antidiabetic Drugs: Imeglimin Exhibits Higher Proton Basicity but Smaller Lithium-Cation Basicity than Metformin in Vacuo. ACS Omega. 2018 Dec 19;3(12):17842-52. |
|
Hussain H, Abbas G, Green IR, Ali I. Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018). Expert opinion on therapeutic patents. 2019 Jul 3;29(7):535-53. |
|
Nisha K. Diabetes Mellitus: Classification, Symptoms and Management: A Review. |
|
Glandt M, Bloomgarden Z. The Future of Diabetes. Principles of Diabetes Mellitus. 2016:1-4. |
|
